Clinical antiarrhythmic drug rational use of.docVIP

 PAGE \* MERGEFORMAT 9 Clinical antiarrhythmic drug rational use of [Abstract] Objective clinical use in patients with cardiac arrhythmias, and analyze its rationality. Methods retrospective investigation, the hospital medical records management system in the random inspection in April 2007 ~ April 2008 among 355 hospitalized patients with cardiac arrhythmias in patients (300 were selected for clinical drug utilization, and clinical application of combination therapy rationality statistics, analysis, conclusion. results in varieties with drugs, I kind of sodium channel blockers, -receptor blockers , calcium channel blockers, drugs commonly used on behalf of quinidine, procainamide, lidocaine, mexiletine, propafenone, flecainide, propranolol, sotalol, amine iodide ketone, benzyl bromide amine, verapamil, in strict accordance with the drug of choice in patients with clinical symptoms, location combination. Conclusion hospital antiarrhythmic drug application is reasonable, consistent with the international drug trends. [Keywords:] rational use of antiarrhythmic drugs arrhythmia Because the incidence of arrhythmia often abnormal impulse formation, impulse conduction abnormalities lead. In recent years, arrhythmia harm people’s health has become a common and serious threat to people’s health. Normal rhythm originated in the sinus node, 60 ~ 100 minutes frequency along the normal atrioventricular conduction system in a certain period of time sequence of atrial and ventricular excited. If the origin of parts of rhythm, impulse conduction, cardiac rhythm and frequency of any exception, is the arrhythmia [1]. At present, anti-arrhythmia drugs can be divided according to their role in disorders are many different kinds of drugs to adapt to the range, if the unreasonable application of the correct waste and can cause adverse drug reactions, causing serious consequences, attention should be paid. 1 Materials 1.1 Tieling County Department of Cardiol